Skip to main content
Erschienen in: Journal of Neurology 5/2015

01.05.2015 | Original Communication

Differentiated clinical presentation of early and late-onset Alzheimer’s disease: is 65 years of age providing a reliable threshold?

verfasst von: Antonio Palasí, Belén Gutiérrez-Iglesias, Montse Alegret, Francesc Pujadas, Mikel Olabarrieta, Diana Liébana, Manolo Quintana, José Álvarez-Sabín, Mercè Boada

Erschienen in: Journal of Neurology | Ausgabe 5/2015

Einloggen, um Zugang zu erhalten

Abstract

Early-onset and late-onset Alzheimer’s disease (EOAD and LOAD) are two forms of the disease with the same characteristic neuropathological hallmarks. However, higher burdens of neuritic plaques and neurofibrillary tangles in frontal and parietal lobes have been found in EOAD than in LOAD patients. Thus, the EOAD subjects may have a differentiated clinical presentation compared to the LOAD ones. Some authors have found less hippocampal memory presentations and more focal cortical abnormalities (such as visuoconstructive or executive dysfunction) in EOAD than LOAD patients. The aim of the present study was to determine which initial clinical profiles differ between EOAD and LOAD; and to analyze whether another age cut-off could discriminate better between EOAD and LOAD clinical presentations than the conventional limit of 65. All patients fulfilling NINCDS-ADRDA criteria for probable Alzheimer’s disease who referred to our Hospital between October 2007 and December 2012 were included in the study. The conventional age limit of 65 was established to distinguish between EOAD and LOAD. Baseline neuropsychological scores, adjusted for age and education, were compared between both groups. A total of 181 patients (38 EOAD, 143 LOAD) entered in the analysis. Sex distribution and time of evolution of symptoms did not differ between groups. The EOAD patients performed worse than LOAD in attentional, imitation praxis and verbal learning tests. In addition, the age cut-off of 70 was found to differentiate between early- and late-onset groups better than the standard cut-off of 65 years old. Our results support a differentiated neuropsychological impairment pattern in EOAD compared to LOAD.
Literatur
1.
Zurück zum Zitat Blessed G, Tomlinson BE, Roth M (1968) The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry 114:797–811CrossRefPubMed Blessed G, Tomlinson BE, Roth M (1968) The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry 114:797–811CrossRefPubMed
2.
Zurück zum Zitat Marshall GA, Fairbanks LA, Tekin S, Vinters HV, Cummings JL (2007) Early-onset Alzheimer’s disease is associated with greater pathologic burden. J Geriatr Psychiatry Neurol 20:29–33CrossRefPubMed Marshall GA, Fairbanks LA, Tekin S, Vinters HV, Cummings JL (2007) Early-onset Alzheimer’s disease is associated with greater pathologic burden. J Geriatr Psychiatry Neurol 20:29–33CrossRefPubMed
3.
Zurück zum Zitat Bigio EH, Hynan LS, Sontag E, Satumtira S, White CL (2002) Synapse loss is greater in presenile than senile onset Alzheimer disease: implications for the cognitive reserve hypothesis. Neuropathol Appl Neurobiol 28:218–227CrossRefPubMed Bigio EH, Hynan LS, Sontag E, Satumtira S, White CL (2002) Synapse loss is greater in presenile than senile onset Alzheimer disease: implications for the cognitive reserve hypothesis. Neuropathol Appl Neurobiol 28:218–227CrossRefPubMed
4.
Zurück zum Zitat Erten-Lyons D, Dodge HH, Woltjer R, Silbert LC, Howieson DB, Kramer P, Kaye JA (2013) Neuropathological basis of age-associated brain atrophy. JAMA Neurol 70:616–622PubMedCentralCrossRefPubMed Erten-Lyons D, Dodge HH, Woltjer R, Silbert LC, Howieson DB, Kramer P, Kaye JA (2013) Neuropathological basis of age-associated brain atrophy. JAMA Neurol 70:616–622PubMedCentralCrossRefPubMed
5.
Zurück zum Zitat Mendez MF, Lee AS, Joshi A, Shapira JS (2012) Nonamnestic presentations of early-onset Alzheimer’s disease. J Alzheimers Dis 27:413–420CrossRef Mendez MF, Lee AS, Joshi A, Shapira JS (2012) Nonamnestic presentations of early-onset Alzheimer’s disease. J Alzheimers Dis 27:413–420CrossRef
6.
Zurück zum Zitat Koss E, Edland S, Fillenbaum G, Mohs R, Clark C, Galasko D, Morris JC (1996) Clinical and neuropsychological differences between patients with earlier and later onset of Alzheimer’s disease: a CERAD analysis, part XII. Neurology 46:136–141CrossRefPubMed Koss E, Edland S, Fillenbaum G, Mohs R, Clark C, Galasko D, Morris JC (1996) Clinical and neuropsychological differences between patients with earlier and later onset of Alzheimer’s disease: a CERAD analysis, part XII. Neurology 46:136–141CrossRefPubMed
7.
Zurück zum Zitat Jacobs D, Sano M, Marder K, Bell K, Bylsma F, Lafleche G, Albert M, Brandt J, Stern Y (1994) Age at onset of Alzheimer’s disease: relation to pattern of cognitive dysfunction and rate of decline. Neurology 44:1215–1220CrossRefPubMed Jacobs D, Sano M, Marder K, Bell K, Bylsma F, Lafleche G, Albert M, Brandt J, Stern Y (1994) Age at onset of Alzheimer’s disease: relation to pattern of cognitive dysfunction and rate of decline. Neurology 44:1215–1220CrossRefPubMed
8.
Zurück zum Zitat Möller C, Vrenken H, Jiskoot L, Versteeg A, Barkhof F, Scheltens P, van der Flier WM (2013) Different patterns of gray matter atrophy in early- and late-onset Alzheimer’s disease. Neurobiol Aging 34:2014–2022CrossRefPubMed Möller C, Vrenken H, Jiskoot L, Versteeg A, Barkhof F, Scheltens P, van der Flier WM (2013) Different patterns of gray matter atrophy in early- and late-onset Alzheimer’s disease. Neurobiol Aging 34:2014–2022CrossRefPubMed
9.
Zurück zum Zitat Gour N, Felician O, Didic M, Koric L, Gueriot C, Chanoine V, Confort-Gouny S, Guye M, Ceccaldi M, Ranjeva JP (2014) Functional connectivity changes differ in early and late-onset Alzheimer’s disease. Hum Brain Mapp 35:2978–2994. doi:10.1002/hbm.22379 CrossRefPubMed Gour N, Felician O, Didic M, Koric L, Gueriot C, Chanoine V, Confort-Gouny S, Guye M, Ceccaldi M, Ranjeva JP (2014) Functional connectivity changes differ in early and late-onset Alzheimer’s disease. Hum Brain Mapp 35:2978–2994. doi:10.​1002/​hbm.​22379 CrossRefPubMed
10.
Zurück zum Zitat Frisoni GB, Pievani M, Testa C, Sabattoli F, Bresciani L, Bonetti M, Beltramello A, Hayashi KM, Toga AW, Thompson PM (2007) The topography of grey matter involvement in early and late onset Alzheimer’s disease. Brain 130:720–730CrossRefPubMed Frisoni GB, Pievani M, Testa C, Sabattoli F, Bresciani L, Bonetti M, Beltramello A, Hayashi KM, Toga AW, Thompson PM (2007) The topography of grey matter involvement in early and late onset Alzheimer’s disease. Brain 130:720–730CrossRefPubMed
11.
Zurück zum Zitat Ishii K, Kawachi T, Sasaki H, Kono AK, Fukuda T, Kojima Y, Mori E (2005) Voxel-based morphometric comparison between early- and late-onset mild Alzheimer’s disease and assessment of diagnostic performance of Z score images. AJNR Am J Neuroradiol 26:333–340PubMed Ishii K, Kawachi T, Sasaki H, Kono AK, Fukuda T, Kojima Y, Mori E (2005) Voxel-based morphometric comparison between early- and late-onset mild Alzheimer’s disease and assessment of diagnostic performance of Z score images. AJNR Am J Neuroradiol 26:333–340PubMed
12.
Zurück zum Zitat Kaiser NC, Melrose RJ, Liu C, Sultzer DL, Jimenez E, Su M, Monserratt L, Mendez MF (2012) Neuropsychological and neuroimaging markers in early versus late-onset Alzheimer’s disease. Am J Alzheimers Dis Other Demen 27:520–529PubMedCentralCrossRefPubMed Kaiser NC, Melrose RJ, Liu C, Sultzer DL, Jimenez E, Su M, Monserratt L, Mendez MF (2012) Neuropsychological and neuroimaging markers in early versus late-onset Alzheimer’s disease. Am J Alzheimers Dis Other Demen 27:520–529PubMedCentralCrossRefPubMed
14.
Zurück zum Zitat Kim EJ, Cho SS, Jeong Y, Park KC, Kang SJ, Kang E, Kim SE, Lee KH, Na DL (2005) Glucose metabolism in early onset versus late onset Alzheimer’s disease: an SPM analysis of 120 patients. Brain 128:1790–1801CrossRefPubMed Kim EJ, Cho SS, Jeong Y, Park KC, Kang SJ, Kang E, Kim SE, Lee KH, Na DL (2005) Glucose metabolism in early onset versus late onset Alzheimer’s disease: an SPM analysis of 120 patients. Brain 128:1790–1801CrossRefPubMed
15.
Zurück zum Zitat Van der Flier WM, Pijnenburg YA, Fox NC, Scheltens P (2011) Early-onset versus late-onset Alzheimer’s disease: the case of the missing APOE ε4 allele. Lancet Neurol 10:280–288CrossRefPubMed Van der Flier WM, Pijnenburg YA, Fox NC, Scheltens P (2011) Early-onset versus late-onset Alzheimer’s disease: the case of the missing APOE ε4 allele. Lancet Neurol 10:280–288CrossRefPubMed
16.
Zurück zum Zitat Seltzer B, Sherwin I (1983) A comparison of clinical features in early and late onset primary degenerative dementia: one entity or two? Arch Neurol 40:143–146CrossRefPubMed Seltzer B, Sherwin I (1983) A comparison of clinical features in early and late onset primary degenerative dementia: one entity or two? Arch Neurol 40:143–146CrossRefPubMed
17.
Zurück zum Zitat Filley CM, Kelly J, Heaton RK (1986) Neuropsychologic features of early- and late-onset Alzheimer’s disease. Arch Neurol 43:574–576CrossRefPubMed Filley CM, Kelly J, Heaton RK (1986) Neuropsychologic features of early- and late-onset Alzheimer’s disease. Arch Neurol 43:574–576CrossRefPubMed
18.
Zurück zum Zitat Smits LL, Pijnenburg YAL, Koedam E, van der Vlies AE, Reuling IEW, Koene T, Teunissen CE, Scheltens P, van der Flier WM (2012) Early onset Alzheimer’s disease is associated with a distinct neuropsychological profile. J Alzheimers Dis 30:101–108PubMed Smits LL, Pijnenburg YAL, Koedam E, van der Vlies AE, Reuling IEW, Koene T, Teunissen CE, Scheltens P, van der Flier WM (2012) Early onset Alzheimer’s disease is associated with a distinct neuropsychological profile. J Alzheimers Dis 30:101–108PubMed
19.
Zurück zum Zitat Sá F, Pinto P, Cunha C, Lemos R, Letra L, Simoes M, Santana I (2012) Differences between early and late-onset Alzheimer’s disease in neuropsychological tests. Front Neurol 3:81PubMedCentralCrossRefPubMed Sá F, Pinto P, Cunha C, Lemos R, Letra L, Simoes M, Santana I (2012) Differences between early and late-onset Alzheimer’s disease in neuropsychological tests. Front Neurol 3:81PubMedCentralCrossRefPubMed
20.
Zurück zum Zitat Koedam E, Lauffer V, van der Vlies AE, van der Flier WM, Scheltens P, Pijnenburg YAL (2010) Early-versus late-onset Alzheimer’s disease: more than age alone. J Alzheimers Dis 19:1401–1408PubMed Koedam E, Lauffer V, van der Vlies AE, van der Flier WM, Scheltens P, Pijnenburg YAL (2010) Early-versus late-onset Alzheimer’s disease: more than age alone. J Alzheimers Dis 19:1401–1408PubMed
21.
Zurück zum Zitat Licht EA, McMurtray AM, Saul RE, Mendez MF (2007) Cognitive differences between early- and late-onset Alzheimer’s disease. Am J Alzheimers Dis Other Demen 22:218–222CrossRefPubMed Licht EA, McMurtray AM, Saul RE, Mendez MF (2007) Cognitive differences between early- and late-onset Alzheimer’s disease. Am J Alzheimers Dis Other Demen 22:218–222CrossRefPubMed
22.
Zurück zum Zitat Grady CL, Haxby JV, Horwitz B, Berg G, Rapoport SI (1987) Neuropsychological and cerebral metabolic function in early vs late onset dementia of the Alzheimer type. Neuropsychologia 25:807–816CrossRefPubMed Grady CL, Haxby JV, Horwitz B, Berg G, Rapoport SI (1987) Neuropsychological and cerebral metabolic function in early vs late onset dementia of the Alzheimer type. Neuropsychologia 25:807–816CrossRefPubMed
23.
Zurück zum Zitat Galton CJ, Patterson K, Xuereb JH, Hodges JR (2000) Atyical and typical presentations of Alzheimer’s disease: a clinical, neuropsychological, neuroimaging and pathological study of 13 cases. Brain 123:484–498CrossRefPubMed Galton CJ, Patterson K, Xuereb JH, Hodges JR (2000) Atyical and typical presentations of Alzheimer’s disease: a clinical, neuropsychological, neuroimaging and pathological study of 13 cases. Brain 123:484–498CrossRefPubMed
24.
Zurück zum Zitat Ross SJ, Graham N, Stuart-Green L, Prins M, Xuereb J, Patterson K, Hodges JR (1996) Progressive biparietal atrophy: an atypical presentation of Alzheimer’s disease. J Neurol Neurosurg Psychiatry 61:388–395PubMedCentralCrossRefPubMed Ross SJ, Graham N, Stuart-Green L, Prins M, Xuereb J, Patterson K, Hodges JR (1996) Progressive biparietal atrophy: an atypical presentation of Alzheimer’s disease. J Neurol Neurosurg Psychiatry 61:388–395PubMedCentralCrossRefPubMed
25.
Zurück zum Zitat McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor MN, Scheltens P, Carrillo MC, Thies B, Weintraub S, Phelps CH (2011) The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7:263–269PubMedCentralCrossRefPubMed McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor MN, Scheltens P, Carrillo MC, Thies B, Weintraub S, Phelps CH (2011) The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7:263–269PubMedCentralCrossRefPubMed
26.
Zurück zum Zitat Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CR, Kaye J, Montine TJ, Park DC, Reiman EM, Rowe CC, Siemers E, Stern Y, Yaffe K, Carrillo MC, Thies B, Morrison-Bogorad M, Wagster MV, Phelps CH (2011) Toward defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7:280–292PubMedCentralCrossRefPubMed Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CR, Kaye J, Montine TJ, Park DC, Reiman EM, Rowe CC, Siemers E, Stern Y, Yaffe K, Carrillo MC, Thies B, Morrison-Bogorad M, Wagster MV, Phelps CH (2011) Toward defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7:280–292PubMedCentralCrossRefPubMed
27.
Zurück zum Zitat Albert M, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carrillo MC, Thies B, Phelps CH (2011) The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7:270–279PubMedCentralCrossRefPubMed Albert M, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carrillo MC, Thies B, Phelps CH (2011) The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7:270–279PubMedCentralCrossRefPubMed
28.
Zurück zum Zitat Dubois B, Feldman HH, Jacova C, DeKosky S, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G, Megura K, O’Brien J, Pasquier F, Robert P, Rossor M, Salloway S, Stern Y, Visser PJ, Scheltens P (2007) Research criteria for the diagnosis of Alzheimer’s disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 6:734–746CrossRefPubMed Dubois B, Feldman HH, Jacova C, DeKosky S, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G, Megura K, O’Brien J, Pasquier F, Robert P, Rossor M, Salloway S, Stern Y, Visser PJ, Scheltens P (2007) Research criteria for the diagnosis of Alzheimer’s disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 6:734–746CrossRefPubMed
30.
Zurück zum Zitat Spalletta G, De Luca V, Padovani A, Rozzini L, Perri R, Bruni A, Canonico V, Trequattrini A, Bellelli G, Pettenati C, Pazzelli F, Caltagirone C, Orfei MD (2013) Early onset versus late onset in Alzheimer’s disease: what is the reliable cut-off? Adv Alzheimer Dis 2:40–47CrossRef Spalletta G, De Luca V, Padovani A, Rozzini L, Perri R, Bruni A, Canonico V, Trequattrini A, Bellelli G, Pettenati C, Pazzelli F, Caltagirone C, Orfei MD (2013) Early onset versus late onset in Alzheimer’s disease: what is the reliable cut-off? Adv Alzheimer Dis 2:40–47CrossRef
31.
Zurück zum Zitat McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s disease. Neurology 34:939–944CrossRefPubMed McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s disease. Neurology 34:939–944CrossRefPubMed
32.
Zurück zum Zitat Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state”. A practical method for grading cognitive states of patients for the clinician. J Psychiatr Res 12:189–198CrossRefPubMed Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state”. A practical method for grading cognitive states of patients for the clinician. J Psychiatr Res 12:189–198CrossRefPubMed
33.
Zurück zum Zitat Sano M, Devanand DP, Richards M, Miller LW, Marder K, Bell K, Dooneief G, Bylsma FW, Lafleche G, Albert M, Folstein M, Stern Y (1995) A standardized technique for establishing onset and duration of symptoms of Alzheimer’s disease. Arch Neurol 52:961–966CrossRefPubMed Sano M, Devanand DP, Richards M, Miller LW, Marder K, Bell K, Dooneief G, Bylsma FW, Lafleche G, Albert M, Folstein M, Stern Y (1995) A standardized technique for establishing onset and duration of symptoms of Alzheimer’s disease. Arch Neurol 52:961–966CrossRefPubMed
34.
Zurück zum Zitat Reitan RM, Davison LA (1974) Clinical neuropsychology: current status and applications. Hemisphere, New York Reitan RM, Davison LA (1974) Clinical neuropsychology: current status and applications. Hemisphere, New York
35.
Zurück zum Zitat Wechsler D (1997) WAIS–III. Wechsler Adult Intelligence Scale. Technical manual, 3rd edn. The Psychological Corporation, San Antonio Wechsler D (1997) WAIS–III. Wechsler Adult Intelligence Scale. Technical manual, 3rd edn. The Psychological Corporation, San Antonio
36.
Zurück zum Zitat Wechsler D (1997) WMS–III. Wechsler Memory Scale. Administration and scoring manual, 3rd edn. The Psychological Corporation, San Antonio Wechsler D (1997) WMS–III. Wechsler Memory Scale. Administration and scoring manual, 3rd edn. The Psychological Corporation, San Antonio
37.
Zurück zum Zitat Kaplan EF, Goodglass H, Weintraub S (1983) The Boston Naming Test, 2nd edn. Lea & Febiger, Philadelphia Kaplan EF, Goodglass H, Weintraub S (1983) The Boston Naming Test, 2nd edn. Lea & Febiger, Philadelphia
38.
Zurück zum Zitat Goodglass H, Kaplan E (1983) The assessment of aphasia and related disorders, 2nd edn. Lea & Febiger, Philadelphia Goodglass H, Kaplan E (1983) The assessment of aphasia and related disorders, 2nd edn. Lea & Febiger, Philadelphia
39.
Zurück zum Zitat Peña-Casanova J (1991) Programa Integrado de Exploración Neuropsicológica. Test Barcelona (Integrated Program of Neuropsychological Assessment. Barcelona Test). Masson, Barcelona, Spain Peña-Casanova J (1991) Programa Integrado de Exploración Neuropsicológica. Test Barcelona (Integrated Program of Neuropsychological Assessment. Barcelona Test). Masson, Barcelona, Spain
40.
Zurück zum Zitat Lezak MD, Howieson DB, Bigler ED, Tranel D (2012) Neuropsychological assessment, 5th edn. Oxford University Press, New York Lezak MD, Howieson DB, Bigler ED, Tranel D (2012) Neuropsychological assessment, 5th edn. Oxford University Press, New York
41.
Zurück zum Zitat Benton AL, Varney NR, Hamsher KS (1978) Visuospatial judgment: a clinical test. Arch Neurol 35:364–367CrossRefPubMed Benton AL, Varney NR, Hamsher KS (1978) Visuospatial judgment: a clinical test. Arch Neurol 35:364–367CrossRefPubMed
42.
Zurück zum Zitat Golden CJ (1980) In reply to Adams “In search of Luria’s battery: a false start”. J Consult Clin Psychol 48:517–521CrossRefPubMed Golden CJ (1980) In reply to Adams “In search of Luria’s battery: a false start”. J Consult Clin Psychol 48:517–521CrossRefPubMed
43.
Zurück zum Zitat Della Sala S, Laiacona M, Trivelli C, Spinnler H (1995) Poppelreuter-Ghent overlapping figures test. Its sensitivity to age, and its clinical use. Arch Clin Neuropsychol 10:511–534CrossRefPubMed Della Sala S, Laiacona M, Trivelli C, Spinnler H (1995) Poppelreuter-Ghent overlapping figures test. Its sensitivity to age, and its clinical use. Arch Clin Neuropsychol 10:511–534CrossRefPubMed
44.
Zurück zum Zitat Loring DW (1985) Neuropsychological patterns of presenile and senile dementia of the Alzheimer type. Neuropsychologia 23:351–357CrossRefPubMed Loring DW (1985) Neuropsychological patterns of presenile and senile dementia of the Alzheimer type. Neuropsychologia 23:351–357CrossRefPubMed
45.
Zurück zum Zitat Reid W, Broe G, Creasey H, Grayson D, McCusker E, Bennett H, Longley W, Sulway MR (1996) Age at onset and pattern of neuropsychological impairment in mild early-stage Alzheimer disease. A study of a community-based population. Arch Neurol 53:1056–1061CrossRefPubMed Reid W, Broe G, Creasey H, Grayson D, McCusker E, Bennett H, Longley W, Sulway MR (1996) Age at onset and pattern of neuropsychological impairment in mild early-stage Alzheimer disease. A study of a community-based population. Arch Neurol 53:1056–1061CrossRefPubMed
46.
Zurück zum Zitat Balasa M, Gelpi E, Antonell A, Rey MJ, Sanchez-Valle R, Molinuevo JL, Lladó A, Neurological Tissue Bank/University of Barcelona/Hospital Clínic NTB/UB/HC Collaborative Group (2011) Clinical features and APOE genotype of patollogically proven early-onset Alzheimer disease. Neurology 76:1720–1725CrossRefPubMed Balasa M, Gelpi E, Antonell A, Rey MJ, Sanchez-Valle R, Molinuevo JL, Lladó A, Neurological Tissue Bank/University of Barcelona/Hospital Clínic NTB/UB/HC Collaborative Group (2011) Clinical features and APOE genotype of patollogically proven early-onset Alzheimer disease. Neurology 76:1720–1725CrossRefPubMed
47.
Zurück zum Zitat Toyota Y, Ikeda M, Shinagawa S, Matsumoto N, Hokoishi K, Fukuhara R, Ishikawa T, Mori T, Adachi H, Komori K, Tanabe H (2007) Comparison of behavioral and psychological symptoms in early-onset and late-onset Alzheimer’s disease. Int J Geriatr Psychiatry 22:896–901CrossRefPubMed Toyota Y, Ikeda M, Shinagawa S, Matsumoto N, Hokoishi K, Fukuhara R, Ishikawa T, Mori T, Adachi H, Komori K, Tanabe H (2007) Comparison of behavioral and psychological symptoms in early-onset and late-onset Alzheimer’s disease. Int J Geriatr Psychiatry 22:896–901CrossRefPubMed
48.
Zurück zum Zitat Krishna R, Moustafa AA, Eby LA, Skeen LC, Myers CE (2012) Learning and generalization in healthy aging: implication for frontostriatal and hippocampal function. Cogn Behav Neurol 25:7–15PubMedCentralCrossRefPubMed Krishna R, Moustafa AA, Eby LA, Skeen LC, Myers CE (2012) Learning and generalization in healthy aging: implication for frontostriatal and hippocampal function. Cogn Behav Neurol 25:7–15PubMedCentralCrossRefPubMed
49.
Zurück zum Zitat Hoogendam YY, Hofman A, van der Geest JN, van der Lugt A, Ikram MA (2014) Patterns of cognitive function in aging: the Rotterdam study. Eur J Epidemiol 29:133–140CrossRefPubMed Hoogendam YY, Hofman A, van der Geest JN, van der Lugt A, Ikram MA (2014) Patterns of cognitive function in aging: the Rotterdam study. Eur J Epidemiol 29:133–140CrossRefPubMed
50.
51.
Zurück zum Zitat Fujimori M, Imamura T, Yamashita H, Hirono N, Ikejiri Y, Shimomura T, Mori E (1998) Age at onset and visuocognitive disturbances in Alzheimer disease. Alzheimer Dis Assoc Disord 12:163–166CrossRefPubMed Fujimori M, Imamura T, Yamashita H, Hirono N, Ikejiri Y, Shimomura T, Mori E (1998) Age at onset and visuocognitive disturbances in Alzheimer disease. Alzheimer Dis Assoc Disord 12:163–166CrossRefPubMed
52.
Zurück zum Zitat Rogers BS, Lippa CF (2012) A clinical approach to early-onset inheritable dementia. Am J Alzheimers Dis Other Demen 27:154–161CrossRefPubMed Rogers BS, Lippa CF (2012) A clinical approach to early-onset inheritable dementia. Am J Alzheimers Dis Other Demen 27:154–161CrossRefPubMed
53.
Zurück zum Zitat Renvoize E, Hanson M, Dale M (2011) Prevalence and causes of young onset dementia in an English health district. Int J Geriatr Psychiatry 26:106–107CrossRefPubMed Renvoize E, Hanson M, Dale M (2011) Prevalence and causes of young onset dementia in an English health district. Int J Geriatr Psychiatry 26:106–107CrossRefPubMed
54.
Zurück zum Zitat Mendez MF (2006) The accurate diagnosis of early-onset dementia. Int J Psychiatry Med 36:401–412CrossRefPubMed Mendez MF (2006) The accurate diagnosis of early-onset dementia. Int J Psychiatry Med 36:401–412CrossRefPubMed
55.
Zurück zum Zitat Forstl H, Burns A, Levy R, Cairns N (1994) Neuropathological correlates of psychotic phenomena in confirmed Alzheimer’s disease. Br J Psychiatry 165:53–59CrossRefPubMed Forstl H, Burns A, Levy R, Cairns N (1994) Neuropathological correlates of psychotic phenomena in confirmed Alzheimer’s disease. Br J Psychiatry 165:53–59CrossRefPubMed
56.
Zurück zum Zitat McMurtray AM, Ringman J, Chao SZ, Licht E, Saul RE, Mendez MF (2006) Family history of dementia in early-onset versus very late-onset Alzheimer’s disease. Int J Geriatr Psychiatry 21:597–598CrossRefPubMed McMurtray AM, Ringman J, Chao SZ, Licht E, Saul RE, Mendez MF (2006) Family history of dementia in early-onset versus very late-onset Alzheimer’s disease. Int J Geriatr Psychiatry 21:597–598CrossRefPubMed
57.
Zurück zum Zitat Lind J, Larsson A, Persson J, Ingvar M, Nilsson LG, Backman L, Adolfsson R, Cruts M, Sleegers K, Van Broeckhoven C, Nyberg L (2006) Reduced hippocampal volume in non-demented carriers of the apolipoprotein E epsilon4: relation to chronological age and recognition memory. Neurosci Lett 396:23–27CrossRefPubMed Lind J, Larsson A, Persson J, Ingvar M, Nilsson LG, Backman L, Adolfsson R, Cruts M, Sleegers K, Van Broeckhoven C, Nyberg L (2006) Reduced hippocampal volume in non-demented carriers of the apolipoprotein E epsilon4: relation to chronological age and recognition memory. Neurosci Lett 396:23–27CrossRefPubMed
Metadaten
Titel
Differentiated clinical presentation of early and late-onset Alzheimer’s disease: is 65 years of age providing a reliable threshold?
verfasst von
Antonio Palasí
Belén Gutiérrez-Iglesias
Montse Alegret
Francesc Pujadas
Mikel Olabarrieta
Diana Liébana
Manolo Quintana
José Álvarez-Sabín
Mercè Boada
Publikationsdatum
01.05.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Neurology / Ausgabe 5/2015
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-015-7698-3

Weitere Artikel der Ausgabe 5/2015

Journal of Neurology 5/2015 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.